ArticleFrontiers in oncology2026

Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia.

Hsin-Yun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.